HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mariane M A Stefani Selected Research

Antigens

1/2018Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.
9/2014Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.
11/2008Antigen-specific T-cell responses of leprosy patients.
11/2007Use of protein antigens for early serological diagnosis of leprosy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mariane M A Stefani Research Topics

Disease

13Leprosy (Hansen's Disease)
01/2020 - 10/2003
2Multibacillary Leprosy
01/2018 - 11/2008
2Infections
09/2014 - 07/2009
2Tuberculosis (Tuberculoses)
09/2014 - 11/2008
2Paucibacillary Leprosy
11/2007 - 10/2003
1Syphilis
01/2019
1Chagas Disease (American Trypanosomiasis)
01/2019
1Communicable Diseases (Infectious Diseases)
01/2018
1Reinfection
06/2017
1HIV Infections (HIV Infection)
07/2009
1Granuloma
10/2003

Drug/Important Bio-Agent (IBA)

4AntigensIBA
01/2018 - 11/2007
4Proteins (Proteins, Gene)FDA Link
09/2014 - 11/2007
3CytokinesIBA
01/2018 - 10/2003
3VaccinesIBA
09/2014 - 11/2008
2GlycolipidsIBA
01/2018 - 11/2007
2AntibodiesIBA
01/2018 - 11/2007
2Rifampin (Rifampicin)FDA LinkGeneric
01/2018 - 11/2007
2Recombinant ProteinsIBA
01/2018 - 11/2008
2Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2009
2DNA (Deoxyribonucleic Acid)IBA
06/2017 - 11/2007
2Interferon-gamma (Interferon, gamma)IBA
09/2014 - 11/2008
2Immunoglobulin G (IgG)IBA
01/2013 - 11/2007
1Genetic Markers (Genetic Marker)IBA
01/2020
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019
1N-acetyltalosaminuronic acid (NAT)IBA
01/2019
1Annexin A1IBA
05/2018
1TrisaccharidesIBA
01/2018
1DisaccharidesIBA
01/2018
1DapsoneFDA Link
01/2018
1Clofazimine (Lamprene)FDA Link
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2018
1I-antigenIBA
01/2018
1Long Noncoding RNAIBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
05/2012
1RNA (Ribonucleic Acid)IBA
07/2009
1Immunoglobulin M (IgM)IBA
11/2007
1Ofloxacin (Ofloxacine)FDA LinkGeneric
11/2007
1Minocycline (Cyclops)FDA LinkGeneric
11/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2003
1ChemokinesIBA
10/2003

Therapy/Procedure

4Therapeutics
01/2018 - 10/2003
1Aftercare (After-Treatment)
01/2018
1Drug Therapy (Chemotherapy)
01/2013
1Prenatal Care (Care, Prenatal)
07/2009
1Highly Active Antiretroviral Therapy (HAART)
11/2004